It is more likely that the level of Mer phosphorylation other than total Mer expression is related with clinical parameters of patients; thus, future studies should evaluate the phosphorylation status of Mer in NSCLC tumor tissues to investigate whether Mer activation frequently occurs and whether it has prognostic or predictive value. The gene discussed is MERTK; the disease is non-small cell lung carcinoma.